NCT05278728 Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05253846 Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05239741 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05235542 A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT05229003 Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC Status RECRUITING Phase PHASE2
NCT05160896 SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT05160727 Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT05153239 Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) Status COMPLETED Phase PHASE3
NCT05148195 A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT05083481 A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05062889 Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients Status SUSPENDED Phase PHASE2
NCT05062317 ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases Status RECRUITING Phase PHASE2
NCT05049863 Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) Status TERMINATED Phase PHASE1
NCT05042934 Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT05039944 SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies Status TERMINATED Phase PHASE2
NCT05031975 Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy Status UNKNOWN Phase PHASE2